Published in:
09-08-2023 | Voriconazole | ORIGINAL PAPER
Posaconazole and risk of cutaneous squamous cell carcinoma after lung transplantation: a single institution, retrospective cohort study
Authors:
Lawrence F. Kuklinski, Alexandra M. Klomhaus, Amy Shen, Natalie Achamallah, Teresa T. Soriano, Rajan Saggar, Stephen S. Weigt
Published in:
Archives of Dermatological Research
|
Issue 9/2023
Login to get access
Excerpt
The use of voriconazole as an antifungal prophylaxis after lung transplantation has shown positive outcomes [
1]. However, it is also associated with an increased risk of post-transplant cutaneous squamous cell carcinoma (SCC). Posaconazole has emerged as a potential alternative, with anecdotal evidence suggesting a lower incidence of SCC compared to voriconazole [
2]. This study aims to investigate the risk of post-transplant SCC among lung transplant recipients receiving different antifungal prophylaxis regimens. …